Stocksigma LogoStocksigma Logo

Balaxi Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results

Balaxi Pharmaceuticals Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated

Balaxi Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results

Balaxi Pharmaceuticals Ltd 路 Intimation 路 12 Nov 2026, 5:30 am

Balaxi Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results Balaxi Pharmaceuticals Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for Q2 and H1 ended 30th Sep'26 (FY26-27). In compliance with SEBI insider trading regulations, the trading window for dealing in company securities remains closed for designated persons from 1st Oct'26 until 48 hours post the formal declaration of the financial results.

Original exchange filing (PDF)

More announcements from Balaxi Pharmaceuticals Ltd

All Balaxi Pharmaceuticals Ltd announcements